Retrophin to Present at the BMO 2020 Prescriptions for Success Healthcare Conference

Rhea-AI Summary

Retrophin, Inc. (NASDAQ: RTRX) announced that CEO Eric Dube will present at the BMO 2020 Prescriptions for Success Healthcare Conference on June 23, 2020, at 10:00 a.m. ET. A live webcast will be available, with an archived replay accessible for 30 days afterward. Retrophin specializes in developing therapies for rare diseases, with its pipeline featuring sparsentan, which is in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN). The company also collaborates on additional rare disease research and supports its R&D through revenue from existing commercial products.

SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., chief executive officer, will present at the BMO 2020 Prescriptions for Success Healthcare Conference on Tuesday, June 23, 2020 at 10:00 a.m. ET.

A live webcast of the presentation will be available at http://ir.retrophin.com/events and an archived replay will be accessible for up to 30 days.

About Retrophin

Retrophin is a biopharmaceutical company specializing in identifying, developing and delivering life-changing therapies to people living with rare disease. The Company’s approach centers on its pipeline featuring sparsentan, a product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN), rare disorders characterized by progressive scarring of the kidney often leading to end-stage renal disease. Research in additional rare diseases is also underway, including partnerships with leaders in patient advocacy and government research to identify potential therapeutics for NGLY1 deficiency and Alagille syndrome, conditions with no approved treatment options. Retrophin’s R&D efforts are supported by revenues from the Company’s commercial products Chenodal^®, Cholbam^®, Thiola^® and Thiola EC^®.

Retrophin.com

Contact:
Chris Cline, CFA                                           
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879              
IR@retrophin.com

           

FAQ

When will Retrophin present at the BMO Healthcare Conference?

Retrophin will present at the BMO 2020 Prescriptions for Success Healthcare Conference on June 23, 2020, at 10:00 a.m. ET.

Where can I watch the Retrophin conference presentation?

A live webcast of the Retrophin presentation will be available at http://ir.retrophin.com/events.

What is the focus of Retrophin's research and development?

Retrophin focuses on therapies for rare diseases, particularly sparsentan for FSGS and IgAN, and is involved in research for other conditions.

How long will the archived Retrophin presentation be available?

The archived replay of the Retrophin presentation will be accessible for 30 days after the live event.

What products support Retrophin's research and development efforts?

Retrophin's R&D is supported by revenues from its commercial products, including Chenodal®, Cholbam®, Thiola®, and Thiola EC®.